LSAK
Lesaka Technologies, Inc.
LSAK trails on the overall score without a compensating advantage in the available component scores.
MSFT
Microsoft Corporation
MSFT has the edge over LSAK overall, supported by stronger valuation and stronger modeled upside.
LSAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
LSAK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
LSAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 111x | $3.32 | — |
| Cheap | 125x | $3.75 | +13% |
| Fair | 140x | $4.19 | +26% |
| Expensive | 146x | $4.39 | +32% |
Historical ranges are pointers, not guarantees.
LSAK has the edge over MSFT in the historical PE scenario, which offers more potential upside but is not a forecast.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
LSAK Forward outlook
There aren't enough analyst estimates for LSAK to show an outlook.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
LSAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.03 | +$1.15 |
| Q2 2026 | $0.03 | +$1.17 |
| Q1 2026 | -$0.40 | +$0.42 |
| Q4 2025 | -$0.68 | -$0.07 |
| Q3 2025 | -$1.12 | -$0.87 |
| Q2 2025 | -$1.14 | -$0.87 |
| Q3 2022 | -$0.69 | -$0.30 |
| Q2 2022 | -$0.75 | -$0.08 |
LSAK has returned to profit: it earned $0.03 per share over the past year, after losing money the year before.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over LSAK on earnings, with more consistent year-over-year improvement.
LSAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $184.6M | +7.7% |
| Q2 2026 | $188.3M | +12% |
| Q1 2026 | $183.1M | +13% |
| Q4 2025 | $178.7M | +1.4% |
| Q3 2025 | $171.4M | +12% |
| Q2 2025 | $168.5M | +15% |
| Q1 2025 | $161.5M | +17% |
| Q4 2024 | $176.2M | +22% |
LSAK's revenue has grown year over year for 19 quarters in a row: $185M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.8 points |
| Q2 2026 | 3.4% | +20 points |
| Q1 2026 | 2.2% | +1.9 points |
| Q4 2025 | 1.2% | +0.8 points |
| Q3 2025 | 0.2% | +0.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | 0.3% | -0.2 points |
| Q4 2024 | 0.4% | -1.1 points |
LSAK's operating margin was −0.6% last quarter, down 0.8 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over LSAK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over LSAK on profitability, with a higher operating margin.
LSAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15M | -404% |
| Q2 2026 | $7.5M | +$18.1M |
| Q1 2026 | $34.2M | +336% |
| Q4 2025 | -$14.8M | +$646K |
| Q3 2025 | $4.9M | +$13M |
| Q2 2025 | -$10.6M | -1229% |
| Q1 2025 | $7.8M | -52% |
| Q4 2024 | -$15.5M | -$13.9M |
LSAK has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
LSAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +198K shares |
| 1 year | +1.7% | +1.3M shares |
| 3 years | +39% | +22.5M shares |
LSAK has 80M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $186,000 |
| Q2 2026 | $28,000 |
| Q1 2026 | $40,000 |
| Q4 2025 | $271,000 |
| Q2 2025 | $1M |
| Q1 2025 | $27,000 |
| Q4 2024 | $12.6M |
| Q2 2024 | $1.3M |
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over LSAK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
LSAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 7.2x | High |
| Q3 2025 | 10.0x | High |
| Q2 2025 | 18.8x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.1x | Elevated |
LSAK's net debt is about 2.3 years of its operating earnings (EBITDA), down from 10 years a year ago.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT has the edge over LSAK on leverage, with a lower net debt burden relative to earnings.
LSAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 5.2 | Oversold |
LSAK's weekly RSI is 28 (oversold) and its Stochastic is 5 (oversold).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
LSAK PE vs Technology Sector
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
LSAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 18% below |
| 20 week MA | $4.40 | 25% below |
| 50 week MA | $4.58 | 28% below |
| 100 week MA | $4.56 | 27% below |
| 200 week MA | $4.39 | 24% below |
LSAK is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over LSAK on trend strength, trading above more of its moving averages.
LSAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.74 | $4.74 | +27% |
| 2021 | $4.74 | $5.41 | +14% |
| 2022 | $5.41 | $3.79 | -30% |
| 2023 | $3.79 | $3.24 | -15% |
| 2024 | $3.24 | $5.25 | +62% |
| 2025 | $5.25 | $4.36 | -17% |
| 2026 YTD | $4.36 | $3.32 | -24% |
LSAK has finished lower in three of the last six years. It's down 24% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over LSAK on returns for 2026, with the stronger performance.